Neil Stahl

Insider Reports History

Entity
Individual
Location
777 Old Saw Mill River Road, Tarrytown, New York
Signature
/s/**Neil E. Stahl
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Neil Stahl:

Stock Role Class Num Shares Value Price $ Report Date Ownership
REGENERON PHARMACEUTICALS, INC. EVP Research and Development Common Stock 50,999 $49.9 M $979.25 Feb 26, 2024 Direct
REGENERON PHARMACEUTICALS, INC. EVP Research and Development Common Stock 5,834 $5.71 M $979.25 Feb 26, 2024 By 401(k) Plan
REGENERON PHARMACEUTICALS, INC. EVP Research and Development Common Stock 4,605 $4.51 M $979.25 Feb 26, 2024 by Spouse as Trustee
REGENERON PHARMACEUTICALS, INC. EVP Research and Development Non-Qualified Stock Option (right to buy) 0 Feb 2, 2024 Direct

Insider Reports Filed by Neil Stahl

Symbol Company Period Transactions Value $ Form Type Date Filed Role
REGN REGENERON PHARMACEUTICALS, INC. Feb 26, 2024 1 0 4 Feb 28, 2024 EVP Research and Development
REGN REGENERON PHARMACEUTICALS, INC. Feb 7, 2024 7 -7,637,954 4 Feb 8, 2024 EVP Research and Development
REGN REGENERON PHARMACEUTICALS, INC. Feb 2, 2024 3 -9,438,846 4 Feb 6, 2024 EVP Research and Development
REGN REGENERON PHARMACEUTICALS, INC. Dec 8, 2023 4 -1,294,591 4 Dec 12, 2023 EVP Research and Development
REGN REGENERON PHARMACEUTICALS, INC. Nov 10, 2023 1 0 4 Nov 14, 2023 EVP Research and Development
REGN REGENERON PHARMACEUTICALS, INC. Aug 21, 2023 6 -21,775,088 4 Aug 23, 2023 EVP Research and Development
REGN REGENERON PHARMACEUTICALS, INC. Dec 16, 2022 2 0 4 Dec 20, 2022 EVP Research and Development
REGN REGENERON PHARMACEUTICALS, INC. Dec 9, 2022 2 -351,028 4 Dec 13, 2022 EVP Research and Development
REGN REGENERON PHARMACEUTICALS, INC. Aug 4, 2022 20 -32,534,918 4 Aug 8, 2022 EVP Research and Development
REGN REGENERON PHARMACEUTICALS, INC. Dec 11, 2021 1 -500,248 4 Dec 14, 2021 EVP Research and Development
REGN REGENERON PHARMACEUTICALS, INC. Dec 8, 2021 2 0 4 Dec 10, 2021 EVP Research and Development
REGN REGENERON PHARMACEUTICALS, INC. Dec 3, 2021 5 -18,858,197 4 Dec 6, 2021 EVP Research and Development
REGN REGENERON PHARMACEUTICALS, INC. May 14, 2021 10 -19,359,184 4 May 18, 2021 EVP Research and Development